BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10660345)

  • 1. Polymorphisms in the human ornithine transcarbamylase gene useful for allele tracking. Mutations in brief no. 193. Online.
    Plante RJ; Tuchman M
    Hum Mutat; 1998; 12(4):289-90. PubMed ID: 10660345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H intragenic polymorphisms and haplotype analysis in the ornithine transcarbamylase (OTC) gene and their relevance for tracking the inheritance of OTC deficiency.
    Climent C; Rubio V
    Hum Mutat; 2002 Nov; 20(5):407-8. PubMed ID: 12402347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations and polymorphisms in the human ornithine transcarbamylase gene.
    Tuchman M
    Hum Mutat; 1993; 2(3):174-8. PubMed ID: 8364586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations and polymorphisms in the human ornithine transcarbamylase gene: mutation update addendum.
    Tuchman M; Plante RJ
    Hum Mutat; 1995; 5(4):293-5. PubMed ID: 7627182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations and polymorphisms in the human ornithine transcarbamylase gene.
    Tuchman M; Jaleel N; Morizono H; Sheehy L; Lynch MG
    Hum Mutat; 2002 Feb; 19(2):93-107. PubMed ID: 11793468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene.
    Yamaguchi S; Brailey LL; Morizono H; Bale AE; Tuchman M
    Hum Mutat; 2006 Jul; 27(7):626-32. PubMed ID: 16786505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of seven novel missense mutations, two splice-site mutations, two microdeletions and a polymorphic amino acid substitution in the gene for ornithine transcarbamylase (OTC) in patients with OTC deficiency.
    Climent C; Rubio V
    Hum Mutat; 2002 Feb; 19(2):185-6. PubMed ID: 11793483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational spectrum and linkage disequilibrium patterns at the ornithine transcarbamylase gene (OTC).
    Azevedo L; Soares PA; Quental R; Vilarinho L; Teles EL; Martins E; Diogo L; Garcia P; Cenni B; Wermuth B; Amorim A
    Ann Hum Genet; 2006 Nov; 70(Pt 6):797-801. PubMed ID: 17044854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a cytogenetic deletion and of four novel mutations (Q69X, I172F, G188V, G197R) affecting the gene for ornithine transcarbamylase (OTC) in Spanish patients with OTC deficiency.
    Climent C; García-Pérez MA; Sanjurjo P; Ruiz-Sanz JI; Vilaseca MA; Pineda M; Campistol J; Rubio V
    Hum Mutat; 1999 Oct; 14(4):352-3. PubMed ID: 10502831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation.
    Ogino W; Takeshima Y; Nishiyama A; Okizuka Y; Yagi M; Tsuneishi S; Saiki K; Kugo M; Matsuo M
    Kobe J Med Sci; 2007; 53(5):229-40. PubMed ID: 18204299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte mRNA analysis of the ornithine transcarbamylase gene in Italian OTCD male patients and manifesting carriers: identification of novel mutations.
    Giorgi M; Morrone A; Donati MA; Ciani F; Bardelli T; Biasucci G; Zammarchi E
    Hum Mutat; 2000 Apr; 15(4):380-1. PubMed ID: 10737985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streamlined assessment of gene variants by high resolution melt profiling utilizing the ornithine transcarbamylase gene as a model system.
    Dobrowolski SF; Ellingson CE; Caldovic L; Tuchman M
    Hum Mutat; 2007 Nov; 28(11):1133-40. PubMed ID: 17565723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular characterization of a new mutation E122G of human ornithine transcarbamylase gene].
    Gao H; Li W; Yan ZH; Jiang MH; Rui DR; He YS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):19-22. PubMed ID: 12579493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal diagnosis of ornithine transcarbamylase deficiency with use of DNA polymorphisms.
    Fox J; Hack AM; Fenton WA; Golbus MS; Winter S; Kalousek F; Rozen R; Brusilow SW; Rosenberg LE
    N Engl J Med; 1986 Nov; 315(19):1205-8. PubMed ID: 3762643
    [No Abstract]   [Full Text] [Related]  

  • 15. The ornithine transcarbamylase (OTC) gene: mutations in 50 Japanese families with OTC deficiency.
    Matsuda I; Tanase S
    Am J Med Genet; 1997 Sep; 71(4):378-83. PubMed ID: 9286441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proportions of spontaneous mutations in males and females with ornithine transcarbamylase deficiency.
    Tuchman M; Matsuda I; Munnich A; Malcolm S; Strautnieks S; Briede T
    Am J Med Genet; 1995 Jan; 55(1):67-70. PubMed ID: 7702100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro demonstration of intra-locus compensation using the ornithine transcarbamylase protein as model.
    Suriano G; Azevedo L; Novais M; Boscolo B; Seruca R; Amorim A; Ghibaudi EM
    Hum Mol Genet; 2007 Sep; 16(18):2209-14. PubMed ID: 17613537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ornithine transcarbamylase gene: new "private" mutations in four patients and study of a polymorphism.
    Tuchman M; Plante RJ; Giguère Y; Lemieux B
    Hum Mutat; 1994; 3(3):318-20. PubMed ID: 8019569
    [No Abstract]   [Full Text] [Related]  

  • 19. Seven new mutations in the human ornithine transcarbamylase gene.
    Tuchman M; Plante RJ; McCann MT; Qureshi AA
    Hum Mutat; 1994; 4(1):57-60. PubMed ID: 7951259
    [No Abstract]   [Full Text] [Related]  

  • 20. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.